Summary & Overview
CPT 61546: Craniotomy for Pituitary Tumor Resection
CPT code 61546 denotes a cranial approach in which bone from the skull is removed to access and resect pituitary tissue or excise a pituitary tumor. This neurosurgical procedure is a high-acuity, specialty operative service with implications for hospital resource use, perioperative care pathways, and payer authorization protocols. Nationally, pituitary tumor resections are clinically significant because they address both endocrine and neurologic morbidity and often require multidisciplinary care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of typical sites of service, common clinical contexts for use of the code, and what to expect in terms of payer recognition and coverage patterns. The publication highlights benchmarks relevant to utilization and billing practice, recent policy or coding guidance that affects coverage and claims processing, and the clinical setting in which 61546 is most commonly reported.
This summary provides clinicians, billing professionals, and policy analysts with a concise reference to the code’s clinical intent, typical care setting, and payer landscape. Data not available in the input is noted where applicable in detailed sections of the full publication.
Billing Code Overview
CPT code 61546 describes a neurosurgical procedure in which the provider removes a portion of the skull bone to access and resect part of the pituitary gland or to excise a pituitary tumor. The service type is neurosurgical pituitary resection/craniotomy for pituitary tumor. The typical site of service is an inpatient or outpatient hospital operating room or a specialized ambulatory surgery center equipped for intracranial neurosurgery.
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient with progressive visual field defects and biochemical evidence of pituitary hormone hypersecretion is evaluated by a multidisciplinary team including neurosurgery and endocrinology. Imaging with MRI identifies a sellar/suprasellar mass consistent with a pituitary macroadenoma exerting pressure on the optic chiasm. After endocrine optimization and informed consent, the patient is scheduled for a transcranial craniotomy for resection of a pituitary tumor when a transsphenoidal approach is not feasible due to tumor extension, prior sinonasal surgery, or cavernous sinus involvement.
The clinical workflow includes preoperative localization imaging (MRI with and without contrast), baseline endocrine testing, anesthesia assessment, and perioperative steroids if indicated. In the operating room, the neurosurgeon performs a craniotomy to remove a portion of skull bone and exposes the sella turcica to resect the pituitary lesion (CPT 61546). Intraoperative adjuncts may include neuronavigation, intraoperative neurophysiologic monitoring, and reconstructive techniques for skull base closure. Postoperatively the patient is monitored in an intensive care or neurosurgical step-down unit, with serial neurologic checks, endocrine assessment for diabetes insipidus or adrenal insufficiency, and follow-up MRI to assess residual tumor and surgical complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 |